DK1004669T3 - Hidtil ukendte differentieringsinhibitor - Google Patents

Hidtil ukendte differentieringsinhibitor

Info

Publication number
DK1004669T3
DK1004669T3 DK98919575T DK98919575T DK1004669T3 DK 1004669 T3 DK1004669 T3 DK 1004669T3 DK 98919575 T DK98919575 T DK 98919575T DK 98919575 T DK98919575 T DK 98919575T DK 1004669 T3 DK1004669 T3 DK 1004669T3
Authority
DK
Denmark
Prior art keywords
inhibitor
newly differentiated
differentiated
newly
differentiated inhibitor
Prior art date
Application number
DK98919575T
Other languages
Danish (da)
English (en)
Inventor
Seiji Sakano
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14876069&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1004669(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of DK1004669T3 publication Critical patent/DK1004669T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK98919575T 1997-05-14 1998-05-13 Hidtil ukendte differentieringsinhibitor DK1004669T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12406497 1997-05-14
PCT/JP1998/002104 WO1998051799A1 (fr) 1997-05-14 1998-05-13 Nouvel inhibiteur de differentiation

Publications (1)

Publication Number Publication Date
DK1004669T3 true DK1004669T3 (da) 2007-08-27

Family

ID=14876069

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98919575T DK1004669T3 (da) 1997-05-14 1998-05-13 Hidtil ukendte differentieringsinhibitor

Country Status (9)

Country Link
US (2) US6664098B1 (de)
EP (1) EP1004669B1 (de)
JP (3) JP4171528B2 (de)
AU (1) AU730782B2 (de)
CA (1) CA2288218C (de)
DE (1) DE69837601T2 (de)
DK (1) DK1004669T3 (de)
ES (1) ES2284205T3 (de)
WO (1) WO1998051799A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU723939B2 (en) 1995-06-28 2000-09-07 Imperial Cancer Research Technology Ltd Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US20060122373A1 (en) 1997-04-04 2006-06-08 Millennium Pharmaceuticals, Inc. Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof
ES2284205T3 (es) * 1997-05-14 2007-11-01 Asahi Kasei Kabushiki Kaisha Nuevo inhibidor de diferenciacion.
WO2000002897A2 (en) * 1998-07-13 2000-01-20 Yale University Delta cleavage products and methods based thereon
WO2000006726A2 (en) * 1998-07-27 2000-02-10 Amgen Inc. Delta-related polypeptides
US6703221B1 (en) 1999-08-19 2004-03-09 Chiron Corporation Notch receptor ligands and uses thereof
WO2001012664A2 (en) * 1999-08-19 2001-02-22 Chiron Corporation Notch receptor ligands and uses thereof
EP1300168B1 (de) 2000-07-10 2010-03-10 Asahi Kasei Medical Co., Ltd. Blutbehandlungsfilter
US20080194022A1 (en) * 2000-08-03 2008-08-14 Clarke Michael F Isolation and use of solid tumor stem cells
US8044259B2 (en) 2000-08-03 2011-10-25 The Regents Of The University Of Michigan Determining the capability of a test compound to affect solid tumor stem cells
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
WO2002016556A1 (fr) * 2000-08-25 2002-02-28 Asahi Kasei Kabushiki Kaisha Milieu de culture de cellule souche et procede de culture utilisant ce milieu
GB0118155D0 (en) * 2001-07-25 2001-09-19 Lorantis Ltd Superantigen
JP2005503792A (ja) * 2001-08-22 2005-02-10 ガラパゴス・ジェノミックス・ナムローゼ・フェンノートシャップ ハイ・スループット・スクリーニングにおいて同定される骨の恒常性のモジュレーター
US20030119771A1 (en) * 2001-08-22 2003-06-26 Rompaey Luc Van Modulators of bone homeostasis identified in a high-throughput screen
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
US7795404B1 (en) 2003-08-08 2010-09-14 Five Prime Therapeutics, Inc. Human soluble notch receptor ligands
US20060134121A1 (en) * 2004-10-29 2006-06-22 Gavin Thurston DII4 antagonists, assays, and therapeutic methods thereof
US8048418B2 (en) 2004-10-29 2011-11-01 Regeneron Pharmaceuticals, Inc. Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
US7906116B2 (en) 2005-09-01 2011-03-15 Parkash Gill Methods for using and identifying modulators of Delta-like 4
WO2007028110A2 (en) * 2005-09-01 2007-03-08 Vasgene Therapeutics, Inc. Methods for using and identifying modulators of delta-like 4
CN102827287B (zh) 2005-10-31 2015-08-12 昂考梅德药品有限公司 用于诊断和治疗癌症的组合物和方法
AU2006308847C1 (en) * 2005-10-31 2012-05-10 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
AU2006326417B2 (en) * 2005-12-16 2012-05-24 Regeneron Pharmaceuticals, Inc. Therapeutic methods for inhibiting tumor growth with Dll4 antagonists
US20080019961A1 (en) * 2006-02-21 2008-01-24 Regents Of The University Of Michigan Hedgehog signaling pathway antagonist cancer treatment
SG175615A1 (en) * 2006-06-06 2011-11-28 Genentech Inc Anti-dll4 antibodies and methods using same
EP2029159A2 (de) * 2006-06-06 2009-03-04 Genentech, Inc. Zusammensetzungen und verfahren zur modulation der gefässentwicklung
CA2664738C (en) 2006-09-29 2017-03-07 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
RU2448979C2 (ru) * 2006-12-14 2012-04-27 Ридженерон Фармасьютикалз, Инк. Антитела человека к дельта-подобному лиганду-4 человека
EP2120996A2 (de) * 2006-12-20 2009-11-25 Vasgene Therapeutics, Inc. Verfahren zum verwenden und identifizieren von modulatoren von delta-like 4
WO2008092002A2 (en) * 2007-01-24 2008-07-31 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing pancreatic cancer
JP5792621B2 (ja) 2008-09-26 2015-10-14 オンコメッド ファーマシューティカルズ インコーポレイテッド ｆｒｉｚｚｌｅｄ結合剤およびその使用
US8551789B2 (en) 2010-04-01 2013-10-08 OncoMed Pharmaceuticals Frizzled-binding agents and their use in screening for WNT inhibitors
CA2742968C (en) 2008-11-07 2020-06-09 Fabrus Llc Combinatorial antibody libraries and uses thereof
HUE029661T2 (en) 2009-10-16 2017-03-28 Oncomed Pharm Inc A therapeutic combination and use of DLL4 antagonist antibodies and antihypertensive agents
CA2782299A1 (en) * 2009-12-01 2011-06-09 Oncomed Pharmaceuticals, Inc. Methods for treating cancers comprising k-ras mutations
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Ｗｎｔ拮抗劑及治療和篩選方法
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
CN107722122B (zh) 2011-09-23 2022-05-27 昂考梅德药品有限公司 Vegf/dll4结合剂及其应用
JP2015536933A (ja) 2012-10-23 2015-12-24 オンコメッド ファーマシューティカルズ インコーポレイテッド Ｗｎｔ経路結合剤を用いて神経内分泌腫瘍を処置する方法
WO2014071018A1 (en) 2012-10-31 2014-05-08 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a dll4 antagonist
WO2014121196A1 (en) 2013-02-04 2014-08-07 Oncomed Pharmaceuticals, Inc. Methods and monitoring of treatment with a wnt pathway inhibitor
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
WO2016070051A2 (en) 2014-10-31 2016-05-06 Oncomed Pharmaceuticals, Inc. Combination therapy for treatment of disease
EP3226828B1 (de) * 2014-12-02 2020-02-12 Dow Global Technologies LLC Mit zinksalz beschichtete polyurethanmikropartikel und verfahren zur herstellung davon
JP6967003B2 (ja) 2015-09-23 2021-11-17 メレオ バイオファーマ ５ インコーポレイテッド がんの処置のための方法および組成物
US20220348617A1 (en) * 2019-05-01 2022-11-03 H. Lee Moffitt Cancer Center And Research Institute, Inc Engineering broadly reactive human notch ligands as novel tools for biomedical applications

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04171762A (ja) * 1990-11-02 1992-06-18 Olympus Optical Co Ltd 固体撮像装置及びその製造方法
JPH04171528A (ja) * 1990-11-06 1992-06-18 Nec Corp 送信データ量圧縮通信方式
IL101728A (en) 1991-05-03 2007-08-19 Univ Yale Human Abandonment and Delta, Restrictive Areas of Effect in Tophoric Proteins, and Methods Based on Them
US5869282A (en) * 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
WO1993012141A1 (en) * 1991-12-11 1993-06-24 Yale University Nucleotide and protein sequences of the serrate gene and methods based thereon
AU723939B2 (en) 1995-06-28 2000-09-07 Imperial Cancer Research Technology Ltd Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
AU716889B2 (en) 1995-11-17 2000-03-09 Asahi Kasei Kogyo Kabushiki Kaisha Differentiation-suppressive polypeptide
DE69736109T2 (de) * 1996-07-16 2007-01-04 Asahi Kasei Kabushiki Kaisha Differenzierungsinhibitor
WO1998045434A1 (en) * 1997-04-04 1998-10-15 Millennium Biotherapeutics, Inc. Novel human delta3 compositions and therapeutic and diagnostic uses therefor
US6121045A (en) * 1997-04-04 2000-09-19 Millennium Biotherapeutics, Inc. Human Delta3 nucleic acid molecules
ES2284205T3 (es) * 1997-05-14 2007-11-01 Asahi Kasei Kabushiki Kaisha Nuevo inhibidor de diferenciacion.
JP4171762B2 (ja) * 1997-05-14 2008-10-29 旭化成株式会社 新規な分化抑制剤
JP3989589B2 (ja) * 1997-05-14 2007-10-10 旭化成株式会社 血管細胞調節剤

Also Published As

Publication number Publication date
CA2288218A1 (en) 1998-11-19
EP1004669B1 (de) 2007-04-18
DE69837601T2 (de) 2007-12-27
JP2008260773A (ja) 2008-10-30
US7022499B2 (en) 2006-04-04
DE69837601D1 (de) 2007-05-31
JP4171528B2 (ja) 2008-10-22
ES2284205T3 (es) 2007-11-01
US6664098B1 (en) 2003-12-16
AU7236598A (en) 1998-12-08
JP4801695B2 (ja) 2011-10-26
JP4714235B2 (ja) 2011-06-29
CA2288218C (en) 2013-03-12
WO1998051799A1 (fr) 1998-11-19
EP1004669A1 (de) 2000-05-31
EP1004669A4 (de) 2004-03-31
AU730782B2 (en) 2001-03-15
JP2008260772A (ja) 2008-10-30
US20030049788A1 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DE69724809D1 (de) Refluxinhibitoren
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
ATA93198A (de) Fluoxetinpellets
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
PT1036083E (pt) Novos 9a-azalidos
ID20285A (id) Katrol tangan
DK0983266T3 (da) Hidtil ukendte tetrahydrosioquinolinthiophencarboximidamider
ATA111897A (de) Kimme
NO20002555L (no) Skjøt
ATE236897T1 (de) 3-benzylpiperidine
ATA112597A (de) Snowboard - bindung
DE69523450T2 (de) Inhibitor
ATA86797A (de) Verschleissschuh
ATA46498A (de) Kunststoffgleitbahn
ATA161897A (de) Zielfernrohr
ATA118697A (de) Zielfernrohr
ATE421585T1 (de) Motlinhomologe
CY2007006I2 (el) Αναστολεις συνθεσεις απολιποπρωτεϊνης-β
BR9701098A (pt) Acerbol
BR9700388A (pt) Fura-fura-areia-aspiral
ATA168597A (de) Formstein